Tenon Medical Inc (TNON) Long-Term Liabilities to Equity

Corporate emblem and logo of Tenon Medical Inc (TNON)

Tenon Medical, Inc. (TNON) generates revenue from the supply of sacroiliac joint stabilization systems to specialized clinics. The history of long-term debt load on capital demonstrates financial stability, where 0.00 is recorded as the baseline value. Strict FDA oversight and patent protection create significant barriers to entry for competitors. A stable market moat is ensured by surgeon loyalty and the uniqueness of its minimally invasive technologies.

TNON Tenon Medical, Inc: Long-Term Debt to Capital in the range 04/28/2023 - 10/31/2026
Manufactured product of Tenon Medical, Inc.

Analyzing the structure of long-term financing is critical for assessing the issuer's financial stability. This indicator correlates loans with maturities exceeding one year against total equity. For orthopedic surgery innovator Tenon Medical, Inc. (TNON), such investments may signify the scaling of production for high-tech systems. The trend in the long-term debt-to-equity ratio allows for a distinction between strategic expansion and a decline in capitalization.

Key competitors

Boston Scientific Corp (BSX) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Edwards Lifesciences Corp (EW)|RMD: Long-Term Liabilities to Equity|Long-Term Debt to Capital PODD (Insulet Corporation)|Zimmer (ZBH) - Long-Term Liabilities to Capital|CooperCompanies - Long-Term Debt to Capital|Invisalign (ALGN) - Long-Term Debt to Equity Ratio|GMED: Long-Term Debt to Capital|TMDX - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital artivion.com|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity IART (Integra LifeSciences Corp)|Long-Term Debt to Capital ESTA (Motiva)|Ratio of Long-Term Indebtedness to Capital iLet Bionic Pancreas (BBNX)|IRMD: Long-Term Debt to Equity Ratio|Long-Term Liabilities to Equity EMBC|TNDM: Long-Term Debt to Capital|Long-Term Liabilities to Capital AxoGen Inc (AXGN)|SIBN (SI-BONE Corp) - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio OFIX (Orthofix Corp)|Long-Term Debt to Equity Ratio BVS (Bioventus Inc.)|KIDS (orthopediatrics.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Treace Medical Concepts, Inc. TMCI|SRTA - Long-Term Debt to Equity Ratio|Carlsmed Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital RxSight Ophthalmic|CLPT: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio STXS|STIM (Neuronetics) - Long-Term Debt to Capital|Sight Sciences Inc. (SGHT) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital OBIO|Long-Term Debt to Equity Ratio anikatherapeutics.com ANIK|Long-Term Debt to Capital NSPR (InspireMD, Inc.)|Long-Term Debt to Capital Jin Medical International Ltd. ZJYL|VANI - Long-Term Debt to Equity|XTNT: Long-Term Debt to Equity|NMTC (NeuroOne Corp) - Long-Term Debt to Equity Ratio|Modular Medical, Inc. - Long-Term Debt to Capital Coefficient|MYO (Myomo, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital envoymedical.com COCH|Long-Term Debt to Equity Vivos Therapeutics, Inc. (VVOS)|enVVeno Medical Corporation (NVNO) - Long-Term Indebtedness to Equity|Sintx Technologies, Inc. - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Lifeward Ltd. LFWD|Autonomix - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital invobioscience.com IVF|Bone Biologics Corp (BBLG) - Long-Term Debt to Equity|Long-Term Liabilities to Equity AXNX (Axonics Inc.)|Long-Term Debt to Equity Biolase, Inc.|Long-Term Debt to Equity Ratio Dynatronics Corp. (DYNT)|Long-Term Debt to Capital FNA|INVO - Long-Term Liabilities to Capital